ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 152 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2015. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,274,000 | -78.8% | 18,795 | -78.0% | 0.00% | -80.0% |
| Q4 2016 | $6,017,000 | -1.4% | 85,583 | -0.5% | 0.02% | 0.0% |
| Q3 2016 | $6,102,000 | +50.1% | 86,025 | +3.5% | 0.02% | +50.0% |
| Q2 2016 | $4,064,000 | -1.1% | 83,089 | +28.1% | 0.01% | 0.0% |
| Q1 2016 | $4,108,000 | -50.8% | 64,880 | -12.9% | 0.01% | -47.4% |
| Q4 2015 | $8,358,000 | +33.7% | 74,507 | +14.8% | 0.02% | +35.7% |
| Q3 2015 | $6,249,000 | -5.9% | 64,880 | 0.0% | 0.01% | +7.7% |
| Q2 2015 | $6,643,000 | +65.4% | 64,880 | +0.3% | 0.01% | +62.5% |
| Q1 2015 | $4,016,000 | +41.5% | 64,680 | 0.0% | 0.01% | +33.3% |
| Q4 2014 | $2,838,000 | -22.5% | 64,680 | 0.0% | 0.01% | -25.0% |
| Q3 2014 | $3,661,000 | +25.7% | 64,680 | -0.3% | 0.01% | +33.3% |
| Q2 2014 | $2,912,000 | -8.2% | 64,880 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $3,172,000 | – | 64,880 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |